Management of Anoperineal Lesions in Crohn's Disease: a French National Society of Coloproctology National Consensus

Overview

Journal Tech Coloproctol

Date 2019 Jan 4

PMID 30604249

Citations 6

Authors

D Bouchard

F Pigot

G Staumont

L Siproudhis

L Abramowitz

P Benfredj

C Brochard

N Fathallah

J-L Faucheron

T Higuero

Y Panis

V de Parades

B Vinson-Bonnet

D Laharie

Affiliations

Soon will be listed here.

Abstract

The French National Society of Coloproctology established national recommendations for the treatment of anoperineal lesions associated with Crohn's disease. Treatment strategies for acute abscesses, active fistulas (active denovo and still active under treatment), fistulas in remission, and rectovaginal fistulas are suggested. Recommendations have been graded following the international recommendations, and when absent, professional agreement has been established. For each situation, practical algorithms have been drawn.

Citing Articles

Efficacy and safety of FiLaC™ for perianal fistulizing Crohn's disease: a systematic review and meta-analysis.

Cao D, Li W, Ji Y, Wang X, Cui Z Tech Coloproctol. 2022; 26(10):775-781.

PMID: 35962294 DOI: 10.1007/s10151-022-02682-1.

Management of perianal fistula in inflammatory bowel disease: identification of prognostic factors associated with surgery.

Casas S, Alvarez-Gallego M, Gazo Martinez J, Gonzalez Alcolea N, Barragan Serrano C, Jimenez A Langenbecks Arch Surg. 2021; 406(4):1181-1188.

PMID: 33515317 DOI: 10.1007/s00423-021-02100-4.

Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn's disease.

Pellino G, Keller D, Sampietro G, Angriman I, Carvello M, Celentano V Tech Coloproctol. 2020; 24(5):421-448.

PMID: 32172396 DOI: 10.1007/s10151-020-02183-z.

FiLaC and Crohn's disease perianal fistulas: a pilot study of 20 consecutive patients.

Alam A, Lin F, Fathallah N, Pommaret E, Aubert M, Lemarchand N Tech Coloproctol. 2020; 24(1):75-78.

PMID: 31893324 DOI: 10.1007/s10151-019-02134-3.

Treatment of complex recurrent fistula-in-ano by surgery combined to autologous bone marrow-derived mesenchymal stroma cells and platelet-rich plasma injection.

Amor I, Lainas P, Kassir R, Chenaitia H, Dagher I, Gugenheim J Int J Colorectal Dis. 2019; 34(10):1795-1799.

PMID: 31455971 DOI: 10.1007/s00384-019-03367-2.

References

Echarri A, Castro J, Barreiro M, Carpio D, Pereira S, Lorenzo A . Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure. J Crohns Colitis. 2010; 4(6):654-60. DOI: 10.1016/j.crohns.2010.07.012. View

Mege D, Frasson M, Maggiori L, Panis Y . Is biological mesh interposition a valid option for complex or recurrent rectovaginal fistula?. Colorectal Dis. 2015; 18(2):O61-5. DOI: 10.1111/codi.13242. View

Sands B, Blank M, Diamond R, Barrett J, van Deventer S . Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study. Aliment Pharmacol Ther. 2006; 23(8):1127-36. DOI: 10.1111/j.1365-2036.2006.02878.x. View

Sandborn W, Feagan B, Rutgeerts P, Hanauer S, Colombel J, Sands B . Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med. 2013; 369(8):711-21. DOI: 10.1056/NEJMoa1215739. View

Yassin N, Askari A, Warusavitarne J, Faiz O, Athanasiou T, Phillips R . Systematic review: the combined surgical and medical treatment of fistulising perianal Crohn's disease. Aliment Pharmacol Ther. 2014; 40(7):741-9. DOI: 10.1111/apt.12906. View

Haennig A, Staumont G, Lepage B, Faure P, Alric L, Buscail L . The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn's disease. Colorectal Dis. 2014; 17(4):311-9. DOI: 10.1111/codi.12851. View

Bouguen G, Siproudhis L, Gizard E, Wallenhorst T, Billioud V, Bretagne J . Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab. Clin Gastroenterol Hepatol. 2013; 11(8):975-81.e1-4. DOI: 10.1016/j.cgh.2012.12.042. View

Cosnes J, Bourrier A, Laharie D, Nahon S, Bouhnik Y, Carbonnel F . Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. Gastroenterology. 2013; 145(4):758-65.e2. DOI: 10.1053/j.gastro.2013.04.048. View

Schwartz D, Wiersema M, Dudiak K, Fletcher J, Clain J, Tremaine W . A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology. 2001; 121(5):1064-72. DOI: 10.1053/gast.2001.28676. View

10.

Colombel J, Sandborn W, Reinisch W, Mantzaris G, Kornbluth A, Rachmilewitz D . Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010; 362(15):1383-95. DOI: 10.1056/NEJMoa0904492. View

11.

Present D, Rutgeerts P, Targan S, Hanauer S, Mayer L, van Hogezand R . Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999; 340(18):1398-405. DOI: 10.1056/NEJM199905063401804. View

12.

Molendijk I, Bonsing B, Roelofs H, Peeters K, Wasser M, Dijkstra G . Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease. Gastroenterology. 2015; 149(4):918-27.e6. DOI: 10.1053/j.gastro.2015.06.014. View

13.

Jones I, Fazio V, Jagelman D . The use of transanal rectal advancement flaps in the management of fistulas involving the anorectum. Dis Colon Rectum. 1987; 30(12):919-23. DOI: 10.1007/BF02554276. View

14.

Maeda Y, Ng S, Durdey P, Burt C, Torkington J, Rao P . Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohn's disease. Br J Surg. 2010; 97(9):1340-7. DOI: 10.1002/bjs.7121. View

15.

Zhang H, Zhou Z, Hu B, Liu D, Peng H, Xie S . Clinical Significance of 2 Deep Posterior Perianal Spaces to Complex Cryptoglandular Fistulas. Dis Colon Rectum. 2016; 59(8):766-74. DOI: 10.1097/DCR.0000000000000628. View

16.

Lee M, Heywood N, Sagar P, Brown S, Fearnhead N . Association of Coloproctology of Great Britain and Ireland consensus exercise on surgical management of fistulating perianal Crohn's disease. Colorectal Dis. 2017; 19(5):418-429. DOI: 10.1111/codi.13672. View

17.

Chande N, Patton P, Tsoulis D, Thomas B, MacDonald J . Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2015; (10):CD000067. PMC: 9578512. DOI: 10.1002/14651858.CD000067.pub3. View

18.

Tanaka S, Matsuo K, Sasaki T, Nakano M, Sakai K, Beppu R . Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed?. Hepatogastroenterology. 2010; 57(97):3-7. View

19.

Allan A, Linares L, Spooner H, Alexander-Williams J . Clinical index to quantitate symptoms of perianal Crohn's disease. Dis Colon Rectum. 1992; 35(7):656-61. DOI: 10.1007/BF02053756. View

20.

Gaertner W, Decanini A, Mellgren A, Lowry A, Goldberg S, Madoff R . Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?. Dis Colon Rectum. 2007; 50(11):1754-60. DOI: 10.1007/s10350-007-9077-3. View